I think it depends on what all is said on the 22nd. That said I think the news will be good, but then it will matter how good. If they say they have funding for manufacturing and they're undergoing human studies (what FDA asked for) and a short timeline ... then this is as good as gold!
Market Data 
Markets 
AI
